Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rowe

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
NPJ Vaccines|October 25, 2024
Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferretsThomas Rowe, Ashley Fletcher, Pavel Svoboda, et al.
Immunohorizons|January 28, 2026
Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferretsRobert A Richardson, Thomas Rowe, Greg A Kirchenbaum, et al.
The Journal of Biological Chemistry|August 28, 2009
A novel class of cyclin-dependent kinase inhibitors identified by molecular docking act through a unique mechanismPatrick Corsino, Nicole Horenstein, David Ostrov, et al.
Influenza and Other Respiratory Viruses|February 13, 2018
Human infection with avian influenza A(H7N2) virus-Virginia, 2002Pauline Terebuh, Akini Adija, Lindsay Edwards, et al.
The Journal of Infectious Diseases|August 13, 2008
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variantNega Ali Goji, Carrie Nolan, Heather Hill, et al.
Plos One|August 29, 2012
Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001Timothy M Uyeki, Doan C Nguyen, Thomas Rowe, et al.
Journal of Infection in Developing Countries|October 15, 2014
CXCL14 deficiency does not impact the outcome of influenza or Escherichia coli infections in miceAbubaker Me Sidahmed, Alberto J Leon, David Banner, et al.
The Journal of Infectious Diseases|September 22, 2017
Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) VariantsFeng Liu, Vic Veguilla, F Liaini Gross, et al.
Cell Reports Methods|June 4, 2026
A DirectView focus reduction assay for high-throughput quantification of neutralizing antibodies against influenza A and B virusesChenchen Feng, Thomas Rowe, Michael Currier, et al.
The Journal of General Virology|August 28, 2010
In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009Thomas Rowe, David Banner, Amber Farooqui, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
NPJ Vaccines|October 25, 2024
Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferretsThomas Rowe, Ashley Fletcher, Pavel Svoboda, et al.
Immunohorizons|January 28, 2026
Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferretsRobert A Richardson, Thomas Rowe, Greg A Kirchenbaum, et al.
The Journal of Biological Chemistry|August 28, 2009
A novel class of cyclin-dependent kinase inhibitors identified by molecular docking act through a unique mechanismPatrick Corsino, Nicole Horenstein, David Ostrov, et al.
Influenza and Other Respiratory Viruses|February 13, 2018
Human infection with avian influenza A(H7N2) virus-Virginia, 2002Pauline Terebuh, Akini Adija, Lindsay Edwards, et al.
The Journal of Infectious Diseases|August 13, 2008
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variantNega Ali Goji, Carrie Nolan, Heather Hill, et al.
Plos One|August 29, 2012
Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001Timothy M Uyeki, Doan C Nguyen, Thomas Rowe, et al.
Journal of Infection in Developing Countries|October 15, 2014
CXCL14 deficiency does not impact the outcome of influenza or Escherichia coli infections in miceAbubaker Me Sidahmed, Alberto J Leon, David Banner, et al.
The Journal of Infectious Diseases|September 22, 2017
Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) VariantsFeng Liu, Vic Veguilla, F Liaini Gross, et al.
Cell Reports Methods|June 4, 2026
A DirectView focus reduction assay for high-throughput quantification of neutralizing antibodies against influenza A and B virusesChenchen Feng, Thomas Rowe, Michael Currier, et al.
The Journal of General Virology|August 28, 2010
In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009Thomas Rowe, David Banner, Amber Farooqui, et al.
Pageof 6